Project
avrg: Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for IRX3
Z-value: 2.17
Motif logo
Transcription factors associated with IRX3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
IRX3
|
ENSG00000177508.12 | IRX3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| IRX3 | hg38_v1_chr16_-_54286763_54286803 | 0.16 | 3.8e-01 | Click! |
Activity profile of IRX3 motif
Sorted Z-values of IRX3 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of IRX3
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr5_+_55024250 | 8.44 |
ENST00000231009.3
|
GZMK
|
granzyme K |
| chr1_+_26317950 | 7.19 |
ENST00000374213.3
|
CD52
|
CD52 molecule |
| chr13_-_46142834 | 7.18 |
ENST00000674665.1
|
LCP1
|
lymphocyte cytosolic protein 1 |
| chr1_+_116754422 | 5.98 |
ENST00000369478.4
ENST00000369477.1 |
CD2
|
CD2 molecule |
| chr2_+_89936859 | 5.65 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
| chr14_-_106038355 | 5.49 |
ENST00000390597.3
|
IGHV2-5
|
immunoglobulin heavy variable 2-5 |
| chr2_-_89222461 | 5.14 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
| chr14_-_106470788 | 4.54 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr2_-_136118142 | 4.23 |
ENST00000241393.4
|
CXCR4
|
C-X-C motif chemokine receptor 4 |
| chr14_-_105987068 | 4.20 |
ENST00000390594.3
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr14_-_106374129 | 4.07 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
| chr4_+_70226116 | 3.78 |
ENST00000317987.6
|
FDCSP
|
follicular dendritic cell secreted protein |
| chr14_-_106012390 | 3.76 |
ENST00000455737.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
| chr14_-_106511856 | 3.75 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr14_-_106154113 | 3.65 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
| chr15_-_21742799 | 3.46 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
| chr6_-_49866527 | 3.39 |
ENST00000335847.9
|
CRISP1
|
cysteine rich secretory protein 1 |
| chr14_-_106349792 | 3.36 |
ENST00000438142.3
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
| chr22_+_22811737 | 3.36 |
ENST00000390315.3
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr5_+_35856883 | 3.26 |
ENST00000506850.5
ENST00000303115.8 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
| chr14_-_106185387 | 3.18 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr14_-_106269133 | 3.09 |
ENST00000390609.3
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr2_-_157444044 | 3.08 |
ENST00000264192.8
|
CYTIP
|
cytohesin 1 interacting protein |
| chr1_+_196819731 | 3.07 |
ENST00000320493.10
ENST00000367424.4 |
CFHR1
|
complement factor H related 1 |
| chr14_-_106005574 | 3.05 |
ENST00000390595.3
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr14_-_106235582 | 3.03 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
| chr6_-_49866453 | 2.99 |
ENST00000507853.5
|
CRISP1
|
cysteine rich secretory protein 1 |
| chr7_-_38249572 | 2.93 |
ENST00000436911.6
|
TRGC2
|
T cell receptor gamma constant 2 |
| chr14_+_21918161 | 2.88 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
| chr2_-_89245596 | 2.85 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
| chr22_+_22818994 | 2.80 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 |
| chr14_-_106811131 | 2.79 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr16_+_72056153 | 2.69 |
ENST00000576168.6
ENST00000567185.7 ENST00000567612.2 |
HP
|
haptoglobin |
| chr4_-_38782970 | 2.67 |
ENST00000502321.5
ENST00000308973.9 ENST00000613579.4 ENST00000361424.6 ENST00000622002.4 |
TLR10
|
toll like receptor 10 |
| chr5_-_156963222 | 2.64 |
ENST00000407087.4
ENST00000274532.7 |
TIMD4
|
T cell immunoglobulin and mucin domain containing 4 |
| chr17_-_31314040 | 2.61 |
ENST00000330927.5
|
EVI2B
|
ecotropic viral integration site 2B |
| chr6_-_107824294 | 2.61 |
ENST00000369020.8
ENST00000369022.6 |
SCML4
|
Scm polycomb group protein like 4 |
| chr10_+_88759997 | 2.56 |
ENST00000404459.2
|
LIPN
|
lipase family member N |
| chr12_-_10098977 | 2.55 |
ENST00000315330.8
ENST00000457018.6 |
CLEC1A
|
C-type lectin domain family 1 member A |
| chr1_+_207104226 | 2.53 |
ENST00000367070.8
|
C4BPA
|
complement component 4 binding protein alpha |
| chr8_-_100712761 | 2.53 |
ENST00000517403.5
|
PABPC1
|
poly(A) binding protein cytoplasmic 1 |
| chr14_-_106579223 | 2.51 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
| chr17_-_31314066 | 2.46 |
ENST00000577894.1
|
EVI2B
|
ecotropic viral integration site 2B |
| chr22_+_39901075 | 2.43 |
ENST00000344138.9
|
GRAP2
|
GRB2 related adaptor protein 2 |
| chr1_+_158289916 | 2.43 |
ENST00000368170.8
|
CD1C
|
CD1c molecule |
| chr11_-_118342691 | 2.42 |
ENST00000300692.9
|
CD3D
|
CD3d molecule |
| chr5_+_93583212 | 2.40 |
ENST00000327111.8
|
NR2F1
|
nuclear receptor subfamily 2 group F member 1 |
| chr1_-_160523204 | 2.39 |
ENST00000368055.1
ENST00000368057.8 ENST00000368059.7 |
SLAMF6
|
SLAM family member 6 |
| chr16_-_55833186 | 2.36 |
ENST00000361503.8
ENST00000422046.6 |
CES1
|
carboxylesterase 1 |
| chr15_-_22185402 | 2.35 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
| chr12_+_69348372 | 2.31 |
ENST00000261267.7
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
| chr12_-_10390023 | 2.24 |
ENST00000240618.11
|
KLRK1
|
killer cell lectin like receptor K1 |
| chr5_-_156935656 | 2.24 |
ENST00000406964.5
|
TIMD4
|
T cell immunoglobulin and mucin domain containing 4 |
| chr14_-_106803221 | 2.23 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
| chr14_-_106771020 | 2.22 |
ENST00000617374.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
| chr12_+_5432101 | 2.22 |
ENST00000423158.4
|
NTF3
|
neurotrophin 3 |
| chr2_+_90004792 | 2.21 |
ENST00000462693.1
|
IGKV2D-24
|
immunoglobulin kappa variable 2D-24 (non-functional) |
| chr14_-_106324743 | 2.20 |
ENST00000390612.3
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
| chr11_-_102874974 | 2.20 |
ENST00000571244.3
|
MMP12
|
matrix metallopeptidase 12 |
| chr4_+_89894846 | 2.20 |
ENST00000264790.7
|
MMRN1
|
multimerin 1 |
| chr1_+_158845798 | 2.19 |
ENST00000438394.1
|
MNDA
|
myeloid cell nuclear differentiation antigen |
| chr15_+_88635626 | 2.17 |
ENST00000379224.10
|
ISG20
|
interferon stimulated exonuclease gene 20 |
| chr1_+_160739286 | 2.17 |
ENST00000359331.8
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
| chr14_-_106593319 | 2.15 |
ENST00000390627.3
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr11_-_118342645 | 2.15 |
ENST00000529594.5
|
CD3D
|
CD3d molecule |
| chr2_+_90038848 | 2.14 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr10_-_95069489 | 2.14 |
ENST00000371270.6
ENST00000535898.5 ENST00000623108.3 |
CYP2C8
|
cytochrome P450 family 2 subfamily C member 8 |
| chr11_-_118225002 | 2.14 |
ENST00000356289.10
ENST00000526620.5 |
JAML
|
junction adhesion molecule like |
| chr9_+_102995308 | 2.12 |
ENST00000612124.4
ENST00000374798.8 ENST00000487798.5 |
CYLC2
|
cylicin 2 |
| chr2_+_90021567 | 2.10 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
| chr5_-_56233287 | 2.07 |
ENST00000513241.2
ENST00000341048.9 |
ANKRD55
|
ankyrin repeat domain 55 |
| chr1_+_160739265 | 2.04 |
ENST00000368042.7
|
SLAMF7
|
SLAM family member 7 |
| chr7_+_142618821 | 2.03 |
ENST00000390393.3
|
TRBV19
|
T cell receptor beta variable 19 |
| chr15_+_37934626 | 2.03 |
ENST00000559502.5
ENST00000558148.5 ENST00000319669.5 ENST00000558158.5 |
TMCO5A
|
transmembrane and coiled-coil domains 5A |
| chr11_-_118342616 | 2.00 |
ENST00000392884.2
|
CD3D
|
CD3d molecule |
| chr3_+_122325237 | 1.95 |
ENST00000264474.4
ENST00000479204.1 |
CSTA
|
cystatin A |
| chr2_-_89177160 | 1.94 |
ENST00000484817.1
|
IGKV2-24
|
immunoglobulin kappa variable 2-24 |
| chr11_+_60971668 | 1.90 |
ENST00000313421.11
|
CD6
|
CD6 molecule |
| chr1_+_160739239 | 1.89 |
ENST00000368043.8
|
SLAMF7
|
SLAM family member 7 |
| chr22_+_36863091 | 1.88 |
ENST00000650698.1
|
NCF4
|
neutrophil cytosolic factor 4 |
| chr11_+_60971777 | 1.88 |
ENST00000542157.5
ENST00000433107.6 ENST00000352009.9 ENST00000452451.6 |
CD6
|
CD6 molecule |
| chr6_-_32192630 | 1.84 |
ENST00000375040.8
|
GPSM3
|
G protein signaling modulator 3 |
| chr15_+_80933358 | 1.83 |
ENST00000560027.1
|
CEMIP
|
cell migration inducing hyaluronidase 1 |
| chr10_-_88952763 | 1.83 |
ENST00000224784.10
|
ACTA2
|
actin alpha 2, smooth muscle |
| chr4_+_73740541 | 1.80 |
ENST00000401931.1
ENST00000307407.8 |
CXCL8
|
C-X-C motif chemokine ligand 8 |
| chr13_+_112376341 | 1.80 |
ENST00000414180.5
ENST00000283550.8 ENST00000443541.5 |
SPACA7
|
sperm acrosome associated 7 |
| chr17_+_36103819 | 1.79 |
ENST00000615863.2
ENST00000621626.1 |
CCL4
|
C-C motif chemokine ligand 4 |
| chr6_-_24798907 | 1.77 |
ENST00000565469.4
|
ARMH2
|
armadillo like helical domain containing 2 |
| chr16_+_85899121 | 1.76 |
ENST00000268638.10
ENST00000565552.1 |
IRF8
|
interferon regulatory factor 8 |
| chr7_-_41703062 | 1.75 |
ENST00000242208.5
|
INHBA
|
inhibin subunit beta A |
| chr14_+_66486356 | 1.75 |
ENST00000636229.1
|
CCDC196
|
coiled-coil domain containing 196 |
| chr2_+_188974364 | 1.74 |
ENST00000304636.9
ENST00000317840.9 |
COL3A1
|
collagen type III alpha 1 chain |
| chr1_+_206897435 | 1.74 |
ENST00000391929.7
ENST00000294984.7 ENST00000611909.4 ENST00000367093.3 |
IL24
|
interleukin 24 |
| chr3_+_111911604 | 1.73 |
ENST00000495180.1
|
PHLDB2
|
pleckstrin homology like domain family B member 2 |
| chr2_-_88992903 | 1.73 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr11_+_57597563 | 1.71 |
ENST00000619430.2
ENST00000457869.1 ENST00000340687.10 ENST00000278407.9 ENST00000378323.8 ENST00000378324.6 ENST00000403558.1 |
SERPING1
|
serpin family G member 1 |
| chr14_+_94581407 | 1.67 |
ENST00000553511.1
ENST00000329597.12 ENST00000554633.5 ENST00000555681.1 ENST00000554276.1 |
SERPINA5
|
serpin family A member 5 |
| chr2_+_118942290 | 1.66 |
ENST00000412481.1
|
MARCO
|
macrophage receptor with collagenous structure |
| chr5_+_160421847 | 1.66 |
ENST00000352433.10
ENST00000517480.1 ENST00000520452.5 ENST00000393964.1 |
PTTG1
|
PTTG1 regulator of sister chromatid separation, securin |
| chr12_-_9733292 | 1.66 |
ENST00000621400.4
ENST00000327839.3 |
CLECL1
|
C-type lectin like 1 |
| chr6_-_32666648 | 1.65 |
ENST00000399082.7
ENST00000399079.7 ENST00000374943.8 ENST00000434651.6 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
| chr16_+_56961942 | 1.65 |
ENST00000200676.8
ENST00000566128.1 |
CETP
|
cholesteryl ester transfer protein |
| chr19_-_54463762 | 1.65 |
ENST00000611161.2
|
LENG9
|
leukocyte receptor cluster member 9 |
| chr1_-_19979607 | 1.65 |
ENST00000400520.8
ENST00000482011.2 ENST00000649436.1 |
PLA2G2A
|
phospholipase A2 group IIA |
| chr7_+_139829242 | 1.61 |
ENST00000455353.6
ENST00000458722.6 ENST00000448866.7 ENST00000411653.6 |
TBXAS1
|
thromboxane A synthase 1 |
| chr11_-_5254741 | 1.61 |
ENST00000444587.1
ENST00000336906.6 ENST00000642908.1 ENST00000647543.1 |
HBG2
ENSG00000284931.1
|
hemoglobin subunit gamma 2 novel protein |
| chr1_+_22637580 | 1.61 |
ENST00000402322.1
|
C1QA
|
complement C1q A chain |
| chr2_-_68952880 | 1.61 |
ENST00000481498.1
ENST00000328895.9 |
GKN2
|
gastrokine 2 |
| chr2_+_142877653 | 1.60 |
ENST00000375773.6
ENST00000409512.5 ENST00000264170.9 ENST00000410015.6 |
KYNU
|
kynureninase |
| chr2_-_87825952 | 1.60 |
ENST00000398146.4
|
RGPD2
|
RANBP2 like and GRIP domain containing 2 |
| chr1_+_241848183 | 1.58 |
ENST00000366548.8
ENST00000423131.5 ENST00000523590.5 |
EXO1
|
exonuclease 1 |
| chr14_+_94581388 | 1.56 |
ENST00000554866.5
ENST00000556775.5 |
SERPINA5
|
serpin family A member 5 |
| chr11_-_60183011 | 1.56 |
ENST00000533023.5
ENST00000420732.6 ENST00000528851.6 |
MS4A6A
|
membrane spanning 4-domains A6A |
| chr6_+_116461364 | 1.55 |
ENST00000368606.7
ENST00000368605.3 |
CALHM6
|
calcium homeostasis modulator family member 6 |
| chr12_-_10884244 | 1.54 |
ENST00000543626.4
|
PRH1
|
proline rich protein HaeIII subfamily 1 |
| chr1_+_158931539 | 1.53 |
ENST00000368140.6
ENST00000368138.7 ENST00000392254.6 ENST00000392252.7 ENST00000368135.4 |
PYHIN1
|
pyrin and HIN domain family member 1 |
| chr6_+_22569554 | 1.51 |
ENST00000510882.4
|
HDGFL1
|
HDGF like 1 |
| chr14_+_100019375 | 1.50 |
ENST00000544450.6
|
EVL
|
Enah/Vasp-like |
| chr6_+_130421086 | 1.49 |
ENST00000545622.5
|
TMEM200A
|
transmembrane protein 200A |
| chr22_+_22395005 | 1.49 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr1_+_203765168 | 1.49 |
ENST00000367217.5
ENST00000442561.7 |
LAX1
|
lymphocyte transmembrane adaptor 1 |
| chr1_-_7853054 | 1.47 |
ENST00000361696.10
|
UTS2
|
urotensin 2 |
| chr19_-_49763295 | 1.47 |
ENST00000246801.8
|
TSKS
|
testis specific serine kinase substrate |
| chr11_-_60183191 | 1.46 |
ENST00000412309.6
|
MS4A6A
|
membrane spanning 4-domains A6A |
| chr11_-_104968533 | 1.44 |
ENST00000444739.7
|
CASP4
|
caspase 4 |
| chr4_+_99816797 | 1.41 |
ENST00000512369.2
ENST00000296414.11 |
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides 1 |
| chr10_+_29289061 | 1.41 |
ENST00000375500.8
ENST00000649382.2 |
LYZL1
|
lysozyme like 1 |
| chr11_-_74697694 | 1.41 |
ENST00000529912.5
|
CHRDL2
|
chordin like 2 |
| chr16_-_55833085 | 1.40 |
ENST00000360526.8
|
CES1
|
carboxylesterase 1 |
| chr9_-_110337808 | 1.38 |
ENST00000374510.8
ENST00000374507.4 ENST00000423740.7 ENST00000374511.7 |
TXNDC8
|
thioredoxin domain containing 8 |
| chr3_+_132597260 | 1.37 |
ENST00000249887.3
|
ACKR4
|
atypical chemokine receptor 4 |
| chr3_-_183555696 | 1.37 |
ENST00000341319.8
|
KLHL6
|
kelch like family member 6 |
| chr2_+_88897230 | 1.37 |
ENST00000390244.2
|
IGKV5-2
|
immunoglobulin kappa variable 5-2 |
| chrX_+_108044967 | 1.37 |
ENST00000415430.7
|
VSIG1
|
V-set and immunoglobulin domain containing 1 |
| chr1_-_113871665 | 1.35 |
ENST00000528414.5
ENST00000460620.5 ENST00000359785.10 ENST00000420377.6 ENST00000525799.1 ENST00000538253.5 |
PTPN22
|
protein tyrosine phosphatase non-receptor type 22 |
| chr5_+_119333151 | 1.33 |
ENST00000513374.1
|
TNFAIP8
|
TNF alpha induced protein 8 |
| chr3_+_171843337 | 1.32 |
ENST00000334567.9
ENST00000619900.4 ENST00000450693.1 |
TMEM212
|
transmembrane protein 212 |
| chr11_+_60280577 | 1.30 |
ENST00000679988.1
|
MS4A4A
|
membrane spanning 4-domains A4A |
| chrX_+_12791353 | 1.30 |
ENST00000380663.7
ENST00000398491.6 ENST00000380668.10 ENST00000489404.5 |
PRPS2
|
phosphoribosyl pyrophosphate synthetase 2 |
| chrX_+_83861126 | 1.26 |
ENST00000621735.4
ENST00000329312.5 |
CYLC1
|
cylicin 1 |
| chr14_+_21736136 | 1.26 |
ENST00000390426.2
|
TRAV4
|
T cell receptor alpha variable 4 |
| chr22_+_22644475 | 1.25 |
ENST00000618722.4
ENST00000652219.1 ENST00000480559.6 ENST00000448514.2 ENST00000652249.1 ENST00000651213.1 |
GGTLC2
|
gamma-glutamyltransferase light chain 2 |
| chr2_+_89985922 | 1.25 |
ENST00000390268.2
|
IGKV2D-26
|
immunoglobulin kappa variable 2D-26 |
| chr10_+_94938649 | 1.24 |
ENST00000461906.1
ENST00000260682.8 |
CYP2C9
|
cytochrome P450 family 2 subfamily C member 9 |
| chr8_-_107498041 | 1.23 |
ENST00000297450.7
|
ANGPT1
|
angiopoietin 1 |
| chrX_+_12906612 | 1.23 |
ENST00000218032.7
|
TLR8
|
toll like receptor 8 |
| chr4_+_89901979 | 1.23 |
ENST00000508372.1
|
MMRN1
|
multimerin 1 |
| chr8_-_63026179 | 1.23 |
ENST00000677919.1
|
GGH
|
gamma-glutamyl hydrolase |
| chrX_+_78747705 | 1.22 |
ENST00000614823.5
ENST00000435339.3 ENST00000514744.5 |
LPAR4
|
lysophosphatidic acid receptor 4 |
| chr14_-_106389858 | 1.21 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
| chr14_-_106025628 | 1.21 |
ENST00000631943.1
|
IGHV7-4-1
|
immunoglobulin heavy variable 7-4-1 |
| chr5_+_169584029 | 1.20 |
ENST00000513795.1
|
SPDL1
|
spindle apparatus coiled-coil protein 1 |
| chr10_-_14572123 | 1.20 |
ENST00000378465.7
ENST00000452706.6 ENST00000622567.4 ENST00000378458.6 |
FAM107B
|
family with sequence similarity 107 member B |
| chr12_-_90955172 | 1.20 |
ENST00000358859.3
|
CCER1
|
coiled-coil glutamate rich protein 1 |
| chr5_+_122160168 | 1.19 |
ENST00000509403.6
ENST00000514637.1 |
ENSG00000250803.6
|
novel zinc finger protein |
| chr19_+_3762705 | 1.18 |
ENST00000589174.1
|
MRPL54
|
mitochondrial ribosomal protein L54 |
| chr7_-_4862015 | 1.16 |
ENST00000404991.2
|
PAPOLB
|
poly(A) polymerase beta |
| chr7_-_122699108 | 1.16 |
ENST00000340112.3
|
RNF133
|
ring finger protein 133 |
| chr6_+_106541111 | 1.14 |
ENST00000457437.1
|
CRYBG1
|
crystallin beta-gamma domain containing 1 |
| chr12_+_10929229 | 1.14 |
ENST00000381847.7
ENST00000396400.4 |
PRH2
|
proline rich protein HaeIII subfamily 2 |
| chr8_-_107497909 | 1.13 |
ENST00000517746.6
|
ANGPT1
|
angiopoietin 1 |
| chr7_-_116030735 | 1.11 |
ENST00000393485.5
|
TFEC
|
transcription factor EC |
| chr8_-_85378105 | 1.11 |
ENST00000521846.5
ENST00000523022.6 ENST00000524324.5 ENST00000519991.5 ENST00000520663.5 ENST00000517590.5 ENST00000522579.5 ENST00000522814.5 ENST00000522662.5 ENST00000523858.5 ENST00000519129.5 |
CA1
|
carbonic anhydrase 1 |
| chrX_-_42778155 | 1.11 |
ENST00000378131.4
|
PPP1R2C
|
PPP1R2C family member C |
| chrX_-_141585011 | 1.10 |
ENST00000370519.3
|
SPANXA1
|
sperm protein associated with the nucleus, X-linked, family member A1 |
| chr1_-_92486916 | 1.10 |
ENST00000294702.6
|
GFI1
|
growth factor independent 1 transcriptional repressor |
| chr5_-_181243880 | 1.10 |
ENST00000511566.5
ENST00000511900.5 ENST00000504726.1 ENST00000512968.5 ENST00000626067.1 ENST00000376817.8 ENST00000513027.3 ENST00000512805.6 ENST00000503081.1 |
RACK1
|
receptor for activated C kinase 1 |
| chr7_+_142587857 | 1.10 |
ENST00000617639.1
|
TRBV14
|
T cell receptor beta variable 14 |
| chrX_+_100644183 | 1.10 |
ENST00000640889.1
ENST00000373004.5 |
SRPX2
|
sushi repeat containing protein X-linked 2 |
| chr3_-_27456743 | 1.10 |
ENST00000295736.9
ENST00000428386.5 ENST00000428179.1 |
SLC4A7
|
solute carrier family 4 member 7 |
| chr1_+_196943738 | 1.09 |
ENST00000367415.8
ENST00000367421.5 ENST00000649283.1 ENST00000476712.6 ENST00000496448.6 ENST00000473386.1 ENST00000649960.1 |
CFHR2
|
complement factor H related 2 |
| chr15_+_69414304 | 1.09 |
ENST00000352331.8
ENST00000679126.1 ENST00000647715.1 ENST00000559279.6 |
KIF23
|
kinesin family member 23 |
| chr7_+_139829153 | 1.08 |
ENST00000652056.1
|
TBXAS1
|
thromboxane A synthase 1 |
| chr1_-_89022827 | 1.08 |
ENST00000370481.9
ENST00000564665.1 |
GBP3
|
guanylate binding protein 3 |
| chr11_+_114296347 | 1.08 |
ENST00000299964.4
|
NNMT
|
nicotinamide N-methyltransferase |
| chr7_-_55516045 | 1.08 |
ENST00000453256.5
|
VOPP1
|
VOPP1 WW domain binding protein |
| chr2_+_201260510 | 1.07 |
ENST00000673742.1
|
CASP8
|
caspase 8 |
| chr2_+_113406368 | 1.07 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
| chr12_-_11269696 | 1.07 |
ENST00000381842.7
|
PRB3
|
proline rich protein BstNI subfamily 3 |
| chr18_-_59318544 | 1.06 |
ENST00000587244.5
|
CPLX4
|
complexin 4 |
| chr1_-_169734064 | 1.06 |
ENST00000333360.12
|
SELE
|
selectin E |
| chr10_+_46375619 | 1.05 |
ENST00000584982.7
ENST00000613703.4 |
ANXA8L1
|
annexin A8 like 1 |
| chr6_+_27138588 | 1.04 |
ENST00000615353.1
|
H4C9
|
H4 clustered histone 9 |
| chr11_+_35189869 | 1.04 |
ENST00000525688.5
ENST00000278385.10 ENST00000533222.5 |
CD44
|
CD44 molecule (Indian blood group) |
| chr11_+_60280531 | 1.03 |
ENST00000532114.6
|
MS4A4A
|
membrane spanning 4-domains A4A |
| chr14_+_88594430 | 1.03 |
ENST00000406216.7
ENST00000557737.1 |
ZC3H14
|
zinc finger CCCH-type containing 14 |
| chr1_-_169764648 | 1.03 |
ENST00000454271.1
ENST00000609271.1 |
ENSG00000230704.1
SELE
|
novel transcript selectin E |
| chr10_+_125973373 | 1.03 |
ENST00000417114.5
ENST00000445510.5 ENST00000368691.5 |
FANK1
|
fibronectin type III and ankyrin repeat domains 1 |
| chr20_-_13990609 | 1.01 |
ENST00000284951.10
ENST00000378072.5 |
SEL1L2
|
SEL1L2 adaptor subunit of ERAD E3 ligase |
| chr11_+_35180279 | 1.01 |
ENST00000531873.5
|
CD44
|
CD44 molecule (Indian blood group) |
| chrX_+_108045050 | 1.01 |
ENST00000458383.1
ENST00000217957.10 |
VSIG1
|
V-set and immunoglobulin domain containing 1 |
| chr1_-_99766620 | 1.01 |
ENST00000646001.2
|
FRRS1
|
ferric chelate reductase 1 |
| chr2_+_168901290 | 1.00 |
ENST00000429379.2
ENST00000375363.8 ENST00000421979.1 |
G6PC2
|
glucose-6-phosphatase catalytic subunit 2 |
| chr1_-_52404387 | 1.00 |
ENST00000371566.1
ENST00000371568.8 |
ORC1
|
origin recognition complex subunit 1 |
| chr3_-_49813880 | 0.99 |
ENST00000333486.4
|
UBA7
|
ubiquitin like modifier activating enzyme 7 |
| chr18_+_9885964 | 0.99 |
ENST00000357775.6
ENST00000306084.6 |
TXNDC2
|
thioredoxin domain containing 2 |
| chr16_+_1528674 | 0.99 |
ENST00000253934.9
|
TMEM204
|
transmembrane protein 204 |
| chr2_-_89297785 | 0.98 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
| chr3_-_149377637 | 0.98 |
ENST00000305366.8
|
TM4SF1
|
transmembrane 4 L six family member 1 |
| chr1_-_38881587 | 0.98 |
ENST00000357771.5
ENST00000621281.1 |
GJA9
ENSG00000274944.4
|
gap junction protein alpha 9 novel protein |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 3.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.9 | 2.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.8 | 2.4 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 0.7 | 2.2 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.6 | 8.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.6 | 1.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.5 | 2.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.5 | 3.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.5 | 1.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.5 | 1.5 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.5 | 82.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.5 | 1.9 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 | 4.2 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.4 | 4.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.4 | 2.0 | GO:0039507 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.4 | 6.6 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.4 | 1.9 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.4 | 1.1 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.4 | 3.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.3 | 5.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.3 | 0.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.3 | 1.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.3 | 4.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.3 | 3.4 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.3 | 8.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.3 | 1.8 | GO:0072144 | glomerular mesangial cell development(GO:0072144) mesenchyme migration(GO:0090131) |
| 0.3 | 0.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.3 | 1.8 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.3 | 5.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.3 | 1.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.3 | 0.8 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.3 | 0.8 | GO:0016488 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.3 | 6.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.3 | 1.3 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.3 | 1.0 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.3 | 0.8 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.2 | 2.0 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 0.2 | 1.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 0.7 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 | 0.2 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.2 | 0.7 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.2 | 2.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.2 | 1.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.2 | 8.9 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.2 | 0.6 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.2 | 1.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 | 1.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.2 | 0.6 | GO:0060003 | copper ion export(GO:0060003) |
| 0.2 | 1.5 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.2 | 2.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.2 | 0.7 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 2.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 1.6 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
| 0.2 | 0.5 | GO:0016999 | antibiotic metabolic process(GO:0016999) detoxification of mercury ion(GO:0050787) |
| 0.2 | 1.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.2 | 0.9 | GO:0032571 | response to vitamin K(GO:0032571) bone regeneration(GO:1990523) |
| 0.2 | 0.5 | GO:0006463 | steroid hormone receptor complex assembly(GO:0006463) |
| 0.2 | 0.3 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.2 | 4.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.2 | 5.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.2 | 3.2 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.2 | 2.1 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.2 | 0.6 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.1 | 0.4 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
| 0.1 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 | 1.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 | 3.3 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 | 0.6 | GO:0072560 | type B pancreatic cell maturation(GO:0072560) |
| 0.1 | 2.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.1 | 0.4 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.1 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.4 | GO:1903123 | regulation of thioredoxin peroxidase activity(GO:1903123) negative regulation of thioredoxin peroxidase activity(GO:1903124) negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation(GO:1903125) Wnt signalosome assembly(GO:1904887) negative regulation of peroxidase activity(GO:2000469) |
| 0.1 | 0.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.6 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.7 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.1 | 0.3 | GO:1903414 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.1 | 2.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 | 2.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 | 0.3 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.1 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 | 2.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.1 | 0.7 | GO:2000782 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.1 | 0.5 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.6 | GO:1903352 | L-ornithine transmembrane transport(GO:1903352) |
| 0.1 | 1.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.1 | 2.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.1 | 0.3 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.1 | 0.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.1 | 0.4 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.1 | 2.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.3 | GO:0100057 | regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 0.1 | 0.6 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 0.1 | 1.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.1 | 0.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 2.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 0.7 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.1 | 15.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.1 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.1 | 6.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 | 0.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.1 | 0.4 | GO:0072011 | glomerular endothelium development(GO:0072011) |
| 0.1 | 0.5 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.1 | 1.3 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 0.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.1 | 1.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.1 | 1.4 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 0.3 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.1 | 0.4 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.9 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 0.4 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 0.1 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 1.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.1 | 1.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.2 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
| 0.1 | 0.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 | 0.5 | GO:0001912 | positive regulation of leukocyte mediated cytotoxicity(GO:0001912) |
| 0.0 | 0.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.0 | 0.9 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.0 | 0.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.0 | 1.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.0 | 1.6 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.2 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.0 | 0.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.0 | 0.6 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.0 | 0.6 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.0 | 0.6 | GO:0008228 | opsonization(GO:0008228) |
| 0.0 | 0.2 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 | 0.5 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 | 0.1 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.0 | 0.6 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.0 | 2.1 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.0 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.0 | 0.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.0 | 1.7 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.0 | 2.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 | 0.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.0 | 2.8 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 1.2 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.0 | 0.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 2.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 | 0.1 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 | 0.9 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.0 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.0 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.0 | 4.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 | 0.9 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.0 | 1.0 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.0 | 0.2 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 | 0.2 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.0 | 1.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 1.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.0 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 1.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.1 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.0 | 1.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 1.9 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.0 | 1.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 | 1.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.0 | 0.4 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.0 | 0.1 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 | 0.1 | GO:0033168 | conversion of ds siRNA to ss siRNA involved in RNA interference(GO:0033168) conversion of ds siRNA to ss siRNA(GO:0036404) |
| 0.0 | 0.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 0.6 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.0 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.1 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.0 | 0.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.0 | 0.0 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.0 | 0.2 | GO:2000795 | lung ciliated cell differentiation(GO:0061141) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.0 | 2.6 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 | 0.6 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 | 0.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.0 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
| 0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.0 | 0.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.6 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 | 0.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.4 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.0 | 0.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.0 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
| 0.0 | 0.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.0 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.2 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 0.3 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.0 | 0.2 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 | 0.9 | GO:0045143 | homologous chromosome segregation(GO:0045143) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.4 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
| 0.8 | 3.2 | GO:0097183 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.7 | 2.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.6 | 35.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.6 | 1.7 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.5 | 6.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.4 | 0.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.4 | 1.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.4 | 2.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.3 | 0.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.3 | 1.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.3 | 1.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.3 | 10.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.2 | 1.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 1.4 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.2 | 3.3 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 2.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.2 | 1.9 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.2 | 2.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.2 | 3.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.2 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.1 | 0.6 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.1 | 1.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.1 | 0.4 | GO:0032473 | cytoplasmic side of mitochondrial outer membrane(GO:0032473) caveola neck(GO:0099400) |
| 0.1 | 2.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 1.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 1.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 6.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 0.3 | GO:0097679 | other organism cytoplasm(GO:0097679) |
| 0.1 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 1.0 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.1 | 2.9 | GO:0036019 | endolysosome(GO:0036019) |
| 0.1 | 1.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 1.9 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 0.3 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.1 | 0.4 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 2.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.1 | 1.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 1.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.6 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 10.5 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.0 | 0.1 | GO:0030849 | X chromosome(GO:0000805) autosome(GO:0030849) |
| 0.0 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
| 0.0 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.0 | 1.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.0 | 3.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.0 | 3.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
| 0.0 | 2.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.3 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.0 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 0.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 0.4 | GO:0060091 | kinocilium(GO:0060091) |
| 0.0 | 0.2 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 4.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 1.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 4.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 0.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.0 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.0 | 2.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 0.1 | GO:0033167 | ARC complex(GO:0033167) |
| 0.0 | 2.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 1.4 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.0 | 1.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.0 | 28.0 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.0 | 1.2 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 6.9 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.2 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.0 | 0.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 3.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.0 | 0.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 0.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 3.3 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 0.9 | 2.7 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.8 | 3.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.7 | 2.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.7 | 3.4 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.6 | 1.7 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.5 | 35.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.4 | 3.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.4 | 1.6 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.4 | 2.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.4 | 1.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.3 | 1.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.3 | 4.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.3 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 3.2 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.3 | 2.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.3 | 5.6 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.3 | 2.2 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.3 | 0.6 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.3 | 2.0 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.3 | 3.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.3 | 2.4 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.3 | 0.8 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.2 | 51.9 | GO:0003823 | antigen binding(GO:0003823) |
| 0.2 | 1.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.2 | 0.8 | GO:0004040 | amidase activity(GO:0004040) |
| 0.2 | 1.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.2 | 2.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.2 | 1.7 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 2.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 0.5 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.2 | 2.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 1.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.2 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
| 0.2 | 1.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 1.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.2 | 0.8 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.2 | 1.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 2.1 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.1 | 0.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 1.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 1.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.1 | 0.4 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) peroxidase inhibitor activity(GO:0036479) |
| 0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.1 | 0.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 1.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.1 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.1 | 1.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.1 | 1.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.1 | 0.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.1 | 4.0 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.1 | 0.3 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.1 | 0.3 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.1 | 0.3 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
| 0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 0.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.1 | 2.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.3 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.1 | 0.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.1 | 3.2 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 6.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 1.4 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.1 | 0.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 0.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 0.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.1 | 1.0 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 1.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.8 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 0.1 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.1 | 0.5 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 0.2 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.1 | 2.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.3 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.1 | 0.2 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
| 0.1 | 5.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 0.4 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.0 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.0 | 1.5 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.0 | 0.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
| 0.0 | 0.8 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.0 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.0 | 0.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.0 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.0 | 10.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.3 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 1.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.0 | 0.2 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.0 | 0.8 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 1.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.1 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 0.0 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 1.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 1.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.0 | 1.4 | GO:0019825 | oxygen binding(GO:0019825) |
| 0.0 | 2.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 0.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 3.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.0 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.0 | 0.3 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.1 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.0 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 7.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 4.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.0 | 1.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 1.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.0 | 2.1 | GO:0005518 | collagen binding(GO:0005518) |
| 0.0 | 0.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.0 | 0.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.0 | 0.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.2 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 3.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.0 | 1.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 1.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.0 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.0 | 0.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.0 | 0.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.0 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
| 0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.1 | 3.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 1.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 7.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 2.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 4.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 2.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 2.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 1.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 4.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 3.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 2.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.0 | 1.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 5.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.7 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 2.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 8.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 1.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.0 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.0 | 1.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.0 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 8.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 1.5 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.0 | 1.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 1.0 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 4.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.3 | 6.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.2 | 4.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 1.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.1 | 3.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 1.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 1.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 1.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 3.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 3.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 2.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.1 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.1 | 1.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 0.8 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.1 | 1.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 0.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.0 | 2.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 1.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 1.6 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 2.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 1.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 1.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 1.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 1.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 0.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 1.4 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.0 | 4.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 2.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 1.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 0.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.0 | 1.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 2.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 1.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 1.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 2.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.0 | 0.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 0.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.0 | 1.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
| 0.0 | 2.2 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 0.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 1.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 0.6 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 0.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.7 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.0 | 1.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 1.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 1.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.0 | 0.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |